FRESENIUS MEDICAL CARE-ADR (FMS) Stock Price, Forecast & Analysis
NYSE:FMS • US3580291066
FMS Key Statistics, Chart & Performance
The current stock price of FMS is 23.37 USD. In the past month the price increased by 3.41%. In the past year, price decreased by -2.54%.
FMS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to FMS. When comparing the yearly performance of all stocks, FMS is a bad performer in the overall market: 67.91% of all stocks are doing better.
FMS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to FMS. FMS has a medium profitability rating, but doesn't score so well on its financial health evaluation.
FMS Financial Highlights
Over the last trailing twelve months FMS reported a non-GAAP Earnings per Share(EPS) of 2.44. The EPS increased by 32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.98% | ||
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| Debt/Equity | 0.65 |
FMS Forecast & Estimates
27 analysts have analysed FMS and the average price target is 27.2 USD. This implies a price increase of 16.4% is expected in the next year compared to the current price of 23.37.
For the next year, analysts expect an EPS growth of -6.53% and a revenue growth 0.74% for FMS
FMS Ownership
FMS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.12 | 103.662B | ||
| CI | THE CIGNA GROUP | 9.08 | 76.627B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 99.09 | 26.98B | ||
| LH | LABCORP HOLDINGS INC | 15.71 | 23.748B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.82 | 23.388B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.883B | ||
| DVA | DAVITA INC | 11.51 | 10.555B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.31 | 8.047B | ||
| RDNT | RADNET INC | 91.23 | 5.821B | ||
| CHE | CHEMED CORP | 17.49 | 5.803B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About FMS
Company Profile
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,916 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Company Info
FRESENIUS MEDICAL CARE-ADR
Else-Kroener-Strasse 1
Bad Homburg vor der Hohe HESSEN 61352 DE
CEO: Rice Powell
Employees: 109916
Phone: 4961726090
FRESENIUS MEDICAL CARE-ADR / FMS FAQ
What does FMS do?
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 109,916 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. The company has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. The company develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The company owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Can you provide the latest stock price for FRESENIUS MEDICAL CARE-ADR?
The current stock price of FMS is 23.37 USD. The price decreased by -0.43% in the last trading session.
Does FMS stock pay dividends?
FRESENIUS MEDICAL CARE-ADR (FMS) has a dividend yield of 3.61%. The yearly dividend amount is currently 0.84.
How is the ChartMill rating for FRESENIUS MEDICAL CARE-ADR?
FMS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the PE ratio for FMS stock?
The PE ratio for FRESENIUS MEDICAL CARE-ADR (FMS) is 9.58. This is based on the reported non-GAAP earnings per share of 2.44 and the current share price of 23.37 USD.
What is the ex-dividend date for FMS stock?
The next ex-dividend date for FRESENIUS MEDICAL CARE-ADR (FMS) is May 23, 2025.
Who owns FRESENIUS MEDICAL CARE-ADR?
You can find the ownership structure of FRESENIUS MEDICAL CARE-ADR (FMS) on the Ownership tab.